About the Gonorrhoea Vaccine
A vaccine has been found to reduce the transmission of Gonorrhoea. The vaccine, an existing Meningococcal B (MenB) vaccine called 4CMenB (Bexsero), is being recommended to primarily targeting gay, bisexual, and other men who have sex with men (GBMSM). This initiative aims to reduce the spread of gonorrhoea and address the increasing rates of antibiotic-resistant strains.
Key Facts
- Vaccine: The 4CMenB vaccine, also used to prevent meningococcal B disease, is being used off-label for gonorrhoea prevention.
- Mechanism: The vaccine works by triggering the body’s immune system to produce antibodies that can also protect against gonorrhoea, as the bacteria causing both diseases are closely related.
- Effectiveness: Studies suggest the vaccine can offer up to 40% protection against gonorrhoea, but it’s not a complete preventative measure. The vaccine’s primary benefit is expected to be at the community level, reducing overall gonorrhoea cases.
- Course This consists of 2 vaccinations, over a 2 to 6 month period.
Do book in with Dr Dan if you’d like to have the vaccine or to discuss this further.
